The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration

Katrin Färber1, Sören Markworth, Ulrike Pannasch

  • 1Cellular Neuroscience, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.

Glia
|December 22, 2007
PubMed

Insights

Microglia migration requires both purinergic and adenosine receptor co-stimulation. The enzyme CD39 is crucial for this process by balancing adenosine levels, impacting brain injury responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the brain's immune cells, are activated by injury.
  • Microglial migration is essential for clearing debris and initiating repair.
  • ATP and adenosine are key signaling molecules in the brain.

Purpose of the Study:

  • To investigate the role of CD39 in microglial migration.
  • To determine the necessity of adenosine co-stimulation for ATP-induced microglial migration.
  • To elucidate the ATP/adenosine balance controlled by CD39 in microglial responses.

Main Methods:

  • Utilized wild-type and CD39-deficient (cd39(-/-)) microglia.
  • Assessed microglial migration in response to ATP and adenosine.
  • Examined microglial accumulation in models of brain injury (ischemia, entorhinal cortex lesion, facial nerve lesion).

Main Results:

  • ATP-triggered microglial migration was impaired in cd39(-/-) microglia.
  • Adenosine co-stimulation or addition of soluble ectonucleotidase restored ATP-induced migration in cd39(-/-) microglia.
  • Microglial accumulation at pathological sites was significantly reduced in cd39(-/-) animals.

Conclusions:

  • Co-stimulation of purinergic and adenosine receptors is essential for microglial migration.
  • CD39 plays a critical role in regulating the ATP/adenosine balance, thereby controlling microglial migration.
  • Targeting CD39 could modulate microglial responses in neurological disorders.

Related Concept Videos